OKYO — OKYO Pharma Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for OKYO Pharma, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
R2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.22 | -13.3 | -16.8 | -7.97 | -8.94 |
| Depreciation | |||||
| Non-Cash Items | 1.77 | 1.44 | 4.64 | 2.53 | 1.68 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.02 | 4.14 | 2.67 | 3.63 | 1.32 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Cash from Operating Activities | -5.47 | -7.7 | -9.49 | -1.81 | -5.94 |
| Capital Expenditures | -0.002 | -0.006 | 0 | -0.001 | -0.006 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | -6 |
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.002 | -0.006 | 0 | -0.001 | -6.01 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.15 | 9.32 | 6.21 | 2.66 | 25 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.32 | 1.62 | -3.28 | 0.734 | 13 |